Intellia Therapeutics, Inc.

{
  "main_header": {
    "sid": 1240494,
    "name": "Intellia Therapeutics, Inc.",
    "stock_name": "Intellia Therapeutics, Inc.",
    "full_name": "Intellia Therapeutics, Inc.",
    "name_url": "stocks-analysis/intellia-therapeutics-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "14.63",
    "chg": 6.35,
    "chgp": "76.69%",
    "dir": 1,
    "prev_price": "8.28",
    "mcapval": "1,625.09",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US45826J1051",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "16.17 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/intellia-therapeutics-inc-1240494-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Intellia Therapeutics Stock Hits Day Low of $8.96 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/intellia-therapeutics-stock-hits-day-low-of-896-amid-price-pressure-3686572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IntelliaTherape_priceRelatedfactors_3686572.png",
        "date": "2025-11-10 17:53:44",
        "description": "Intellia Therapeutics, Inc. has faced significant stock volatility, hitting an intraday low and experiencing a substantial year-to-date decline. The company reported negative operating cash flow and a decrease in net sales, with long-term growth prospects appearing limited amid ongoing challenges in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Intellia Therapeutics Faces Weak Start with 10.21% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/intellia-therapeutics-faces-weak-start-with-1021-gap-down-amid-market-concerns-3712440",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IntelliaTherape_gapdown_3712440.png",
        "date": "2025-10-31 16:45:40",
        "description": "Intellia Therapeutics, Inc. opened with a notable loss, reflecting a significant downturn over the past month. The company, with a market capitalization of approximately USD 1.27 billion, is currently loss-making and faces mixed technical indicators amid cautious market sentiment in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 19,
    "sid": "1240494",
    "stock_news_url": "https://www.marketsmojo.com/news/intellia-therapeutics-inc-1240494"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Intellia Therapeutics Stock Hits Day Low of $8.96 Amid Price Pressure

2025-11-10 17:53:44

Intellia Therapeutics, Inc. has faced significant stock volatility, hitting an intraday low and experiencing a substantial year-to-date decline. The company reported negative operating cash flow and a decrease in net sales, with long-term growth prospects appearing limited amid ongoing challenges in the pharmaceuticals and biotechnology sector.

Read full news article

Intellia Therapeutics Faces Weak Start with 10.21% Gap Down Amid Market Concerns

2025-10-31 16:45:40

Intellia Therapeutics, Inc. opened with a notable loss, reflecting a significant downturn over the past month. The company, with a market capitalization of approximately USD 1.27 billion, is currently loss-making and faces mixed technical indicators amid cautious market sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News